Erika Laskey insider trades: Chad Therapeutics (CTU) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Erika reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 28, 2007 | CTU | ↓ Sell | 8,046 | $1.65 | $13K | Retirement Plan | Mar 1, 2007 (1d) |
| Feb 26, 2007 | CTU | ↓ Sell | 8,046 | $1.60 | $13K | Retirement Plan | Feb 27, 2007 (1d) |
| Feb 22, 2007 | CTU | ↓ Sell | 6,419 | $1.59 | $10K | Retirement Plan | Feb 23, 2007 (1d) |
| Feb 15, 2007 | CTU | ↓ Sell | 5,628 | $1.67 | $9K | Retirement Plan | Feb 20, 2007 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Erika Laskey's insider trades
Erika Laskey is Sr. VP of Sales/Marketing at Chad Therapeutics (CTU). Since Feb 15, 2007, Erika has reported no open-market purchases and 4 sales worth $46K on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CTU insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.